Jaffetilchin Investment Partners’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-2,995
Closed -$270K 900
2024
Q3
$270K Sell
2,995
-1,737
-37% -$146K 0.02% 311
2024
Q2
$372K Sell
4,732
-6,586
-58% -$540K 0.03% 255
2024
Q1
$986K Buy
11,318
+3,056
+37% +$261K 0.09% 134
2023
Q4
$681K Buy
+8,262
New +$630K 0.07% 179
2023
Q3
Sell
-6,655
Closed -$586K 361
2023
Q2
$586K Buy
6,655
+2,833
+74% +$244K 0.06% 181
2023
Q1
$308K Buy
3,822
+1,035
+37% +$84.4K 0.04% 282
2022
Q4
$217K Sell
2,787
-732
-21% -$59.3K 0.03% 324
2022
Q3
$284K Buy
+3,519
New +$316K 0.04% 258
2020
Q1
Sell
-2,380
Closed -$270K 201
2019
Q4
$270K Buy
2,380
+301
+14% +$33K 0.06% 180
2019
Q3
$226K Buy
+2,079
New +$217K 0.05% 199
2019
Q2
Sell
-3,420
Closed -$311K 306
2019
Q1
$311K Buy
+3,420
New +$306K 0.07% 209
2014
Q1
Sell
-12,503
Closed -$718K 209
2013
Q4
$718K Buy
+12,503
New +$709K 0.35% 69

Other funds holding MDT

Jaffetilchin Investment Partners's MDT Position: Q4 2024 in Review

Jaffetilchin Investment Partners sold out of Medtronic (MDT) in Q4 2024, closing a stake of 2,995 shares — an estimated $270K sold.

Jaffetilchin Investment Partners first reported a position in MDT in Q4 2013 and held it in 12 quarters. The position peaked at $986K in Q1 2024. 2,124 funds tracked by Wall St. Rank hold MDT as of Q4 2024.

  • Jaffetilchin Investment Partners reported no remaining Medtronic position as of Q4 2024 after selling out during the quarter.
  • Jaffetilchin Investment Partners sold 2,995 Medtronic shares in Q4 2024, an estimated $270K.
  • Jaffetilchin Investment Partners first reported a position in Medtronic in Q4 2013 and held it in 12 quarters.
  • Jaffetilchin Investment Partners's Medtronic position peaked at $986K in Q1 2024.
  • 2,124 funds tracked by Wall St. Rank held Medtronic as of Q4 2024.

Based on Jaffetilchin Investment Partners's 13F filing for Q4 2024, filed 13 Feb 2025.